Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Maturitas ; 67(1): 72-7, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20570453

RESUMEN

OBJECTIVE: In obese postmenopausal women we assessed leptin and adiponectin, high-sensitive C-reactive protein (hsCRP), serum lipids and lipoxidative stress products: oxidized LDL (oxLDL) and malondialdehyde (MDA), in relation to impaired glucose tolerance (IGT). METHODS: Thirty-eight overweight/obese postmenopausal women were included in the study. Eighteen with normal glucose metabolism (NGT) and twenty with IGT, as it is diagnosed by OGTT. Serum leptin, adiponectin, hsCRP and MDA were measured at time 0 and 120 min of OGTT while total-cholesterol, LDL, HDL, triglycerides, oxLDL and anti-oxLDL autoantibodies at time 0. Insulin resistance (HOMA)/sensitivity (QUICKI) indexes were estimated. RESULTS: In subjects with NGT, hsCRP was positively correlated with fasting leptin and HOMA, while in subjects with IGT negatively with QUICKI. In both groups, hsCRP was positively correlated with fasting insulin, body mass index and waist circumference. Fasting adiponectin was positively associated with HDL in both groups and negatively with triglycerides in subjects with NGT as well as with serum glucose levels at time 120 min of OGTT in subjects with IGT. No association was observed between oxLDL and adipokines. A significant positive association was found between oxLDL and HOMA in subjects with IGT. During OGTT there was a significant increase of leptin and MDA levels in both groups. CONCLUSIONS: A relationship exists between obesity, insulin and sub-clinical inflammation. Leptin and lipid peroxidation are linked to hyperglycaemic state while oxLDL might be considered as a predictor of insulin resistance. Adiponectin could exert its antiatherogenic effect through HDL independently of the presence of IGT.


Asunto(s)
Adipoquinas/sangre , Proteína C-Reactiva/metabolismo , Trastornos del Metabolismo de la Glucosa/sangre , Peroxidación de Lípido , Obesidad/sangre , Adipocitos/metabolismo , Adiponectina/sangre , Anciano , Glucemia/metabolismo , Índice de Masa Corporal , Ayuno , Femenino , Trastornos del Metabolismo de la Glucosa/complicaciones , Prueba de Tolerancia a la Glucosa , Humanos , Insulina/sangre , Leptina/sangre , Lípidos/sangre , Malondialdehído/sangre , Persona de Mediana Edad , Obesidad/complicaciones , Posmenopausia/sangre , Valores de Referencia , Circunferencia de la Cintura
2.
Atherosclerosis ; 205(1): 279-83, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19110250

RESUMEN

OBJECTIVE: The aim of the present study was to estimate circulating oxidized low-density lipoprotein (oxLDL) levels in postmenopausal women and evaluate their association with obesity and smoking status. DESIGN AND METHODS: The study included 135 postmenopausal women aged 52-75 years. Forty of them were overweight (BMI 32.4+/-6.4) and non-smokers (Group A), 40 non-overweight (BMI 22.6+/-1.8) and smokers (Group B) and 55 non-overweight (BMI 23.5+/-1.4) and non-smokers (Group C). oxLDL and antibodies against them (anti-oxLDL) were measured using ELISA. Serum total cholesterol, LDL, HDL and triglycerides were measured in an automated analyzer. RESULTS: Total cholesterol, LDL, HDL and oxLDL serum levels were significantly elevated in Group A as compared to Group B or C, as well as oxLDL in Group B in comparison to Group C (p<0.001). Triglycerides and anti-oxLDL were increased in Group A in comparison to Group C (p=0.043 and 0.023). Total cholesterol, LDL, triglycerides and anti-oxLDL did not differ between Groups B and C, while HDL was decreased in Group B as compared to Group C (p<0.001). A significant positive correlation was found between oxLDL and LDL in Group A (r=0.53, p<0.001) as well as in Group C (r=0.955, p

Asunto(s)
Lipoproteínas LDL/metabolismo , Obesidad/sangre , Fumar , Anciano , Índice de Masa Corporal , Femenino , Humanos , Lipoproteínas LDL/sangre , Persona de Mediana Edad , Obesidad/complicaciones , Posmenopausia , Análisis de Regresión , Factores de Riesgo , Tabaquismo/complicaciones
3.
J Sports Med Phys Fitness ; 48(1): 90-6, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18212715

RESUMEN

AIM: Recent investigations have suggested the occurrence of transient cardiac dysfunction and reversible myocardial injury in healthy individuals after heavy exercise. Our purpose was to examine if the release of N-terminal pro-brain natriuretic peptide (NT-proBNP) after intense exercise in obviously healthy participants may have cytoprotective and growth-regulating effects or may result from myocardial dysfunction/damage with changes in cTnT as a marker for myocardial cell necrosis during exercise. METHODS: In 43 highly-trained male athletes <35 years old, who were examined immediately after exercising as well as 2 days later, 21 age-matched male patients classified as stage-B according to ACC/AHA guidelines and 35 healthy age-matched males, we evaluated NT-proBNP and 3rd generation's cTnT by electrochemiluminescence immunoassay. All participants underwent a detailed cardiac protocol including echocardiography and electrocardiogram (ECG). RESULTS: In athletes, cTnT consistently remained <0.01 mg/L after exercising as well as after 2 days. NTproBNP immediately after exercising was 58.27+/-19.48 ng/L, without reaching pathological levels, decreasing 2 days later to 22.93+/-10.22 ng/L. Our patients maintained high levels of NTproBNP, as much as a six-fold increase with reference to the levels of our study's control group and with cTnT <0.01 mg/L. In the control group, cTnT and NTproBNP levels were statistically similar with those of the athletes 2 days after exercising. NT-proBNP as a biological marker can reliably discriminate pathological from physiological cardiac hypertrophy. CONCLUSION: A normal plasma concentration of NT-proBNP in consecutive routine check-up, before and after exercise, could minimize the possibility of cardiac dysfunction, whereas persistent elevated plasma concentrations warrant further cardiological evaluation.


Asunto(s)
Citoprotección , Ejercicio Físico/fisiología , Miocardio , Péptido Natriurético Encefálico/sangre , Fragmentos de Péptidos/sangre , Adulto , Biomarcadores/sangre , Indicadores de Salud , Humanos , Masculino , Miocardio/metabolismo , Miocardio/patología , Educación y Entrenamiento Físico , Aptitud Física , Proyectos Piloto , Medicina Deportiva , Troponina/sangre
4.
Minerva Med ; 97(3): 287-93, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16855523

RESUMEN

Bisalbuminemia is a rare inherent or acquired abnormality characterized by the occurrence of 2 distinct albumin bands or a single widened albumin band, after electrophoretic screening of blood proteins. Despite the fact that the presence of 2 albumin bands in electrophoresis, representing normal and variant protein, is observed with a frequency of 0.00030.0010 in the average population, its role in various pathological states has not yet been clearly defined. Until now, the only disorders which have been directly linked with the presence of congenital bisalbuminemia are familial dysalbuminemic hyperthyroxinemia (Arg218AEHis and Arg218AE Pro mutations) and hypertriiodothyroninemia (Leu66AEPro mutation), while acquired types of bisalbuminemia have been reported after an overdose of beta-lactam antibiotics and as a consequence of severe pancreatitis. We present a case of bisalbuminemia in an adult man who was referred to our laboratory with a prolonged history of recurrent abdominal pain and review the recent literature in order to better familiarize clinicians as well as laboratory personnel with this entity. The biochemical parameters assessed did not show any alteration which could correlate the protein disorder with any distinct pathology.


Asunto(s)
Albúmina Sérica/química , Electroforesis de las Proteínas Sanguíneas , Electroforesis en Gel de Agar , Mutación del Sistema de Lectura/genética , Humanos , Masculino , Persona de Mediana Edad , Mutación Puntual/genética , Albúmina Sérica/genética
5.
In Vivo ; 19(4): 797-800, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15999552

RESUMEN

BACKGROUND: The serum CA 125 marker is elevated in 80% of patients with ovarian adenocarcinoma. MDR 1 gene expression has been identified in a variety of tumor types and its expression has been correlated with multidrug resistance. Whether there is a correlation between CA 125 levels and MDR 1 expression has not been sufficiently investigated. Therefore, the aim of this study was to examine whether an association between serum CA 125 levels and MDR 1 expression exists. PATIENTS AND METHODS: Serum CA 125 levels were measured during the diagnosis of ovarian cancer. Fresh tumor specimens or ascitic fluid samples were studied for MDR 1 expression by the polymerase chain reaction method (PCR). RESULTS: Forty patients with ovarian cancer were studied, 34 (85%) of whom had elevated CA 125. Twenty-eight out of the 40 patients were tested for MDR 1 expression; 20 expressed the gene and 8 did not. The median level of CA 125 in specimens expressing the MDR1 gene was 327, and in specimens that did not it was 376. There was no correlation between the CA 125 levels and MDR 1 expression (p = 0.484). CONCLUSION: There does not seem to be an association between CA 125 levels and expression of the MDR1 gene in patients with ovarian cancer.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Adenocarcinoma/metabolismo , Antígeno Ca-125/sangre , Neoplasias Ováricas/metabolismo , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Adenocarcinoma/genética , Adenocarcinoma/patología , Adulto , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Ováricas/genética , Neoplasias Ováricas/patología , Reacción en Cadena de la Polimerasa
6.
Eur J Obstet Gynecol Reprod Biol ; 121(1): 77-80, 2005 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-15989987

RESUMEN

OBJECTIVE: To examine whether exogenous LH administration has a beneficial effect on the quality of oocytes, fertilization potential, as well as pregnancy rate in IVF-ET cycles. A randomized trial comparing r-FSH versus r-FSH and LH was employed. STUDY DESIGN: Forty-six infertile couples entering IVF-ET for the first time (either tubal or male factor) were divided after prospective randomization into two groups. In both groups the long protocol with GnRH-analogs was used. In group A, ovarian stimulation started with r-FSH (200 IU/day) for the first four days. In group B, the stimulation protocol started with one amp hMG (75 IU FSH + 75 IU LH activity) daily for four days, with simultaneous administration of r-FSH (150 IU/day). The outcome was compared. RESULTS: Statistical difference was observed in the number of mature oocytes, the number of fertilized oocytes as well as the number of transferable embryos. In all cases, results were statistically significantly better (p < 0.05) in group B. Clinical pregnancy rate, finally, was similar in the two groups. CONCLUSION: The relatively small sample size does not allow a definitive conclusion for the important role of LH during early oocyte maturation. Our results, however, indicate a beneficial effect when small doses of LH are used for ovarian stimulation in IVF-ET cycles. This effect may be more important in cases in which few embryos are available for transfer.


Asunto(s)
Fertilización In Vitro/métodos , Hormona Folículo Estimulante/administración & dosificación , Hormona Luteinizante/administración & dosificación , Inducción de la Ovulación/métodos , Adulto , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Estudios de Seguimiento , Humanos , Infertilidad Femenina/terapia , Oocitos/efectos de los fármacos , Oocitos/fisiología , Embarazo , Índice de Embarazo , Estudios Prospectivos , Valores de Referencia , Medición de Riesgo , Resultado del Tratamiento
7.
Clin Exp Immunol ; 135(2): 240-6, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-14738451

RESUMEN

In attempt to investigate the stimulatory effect of Pseudomonas aeruginosa on innate immunity and to correlate it to its level of resistance to antimicrobials, 20 isolates were applied; 8 isolates were susceptible and 12 multidrug-resistant. Genetic diversity was defined by PFGE. Human monocytes of two healthy volunteers were in vitro stimulated by the isolates for the production of pro-inflammatory (TNF-alpha, IL-1beta, IL-6, IL-8 and IL-12) and anti-inflammatory cytokines (IL-10), of malondialdehyde and of procalcitonin. Cytokines were estimated by EIA, malondialdehyde by the thiobarbiturate assay and procalcitonin by an immunochemiluminometric assay. Survival of 48 Wistar rats was recorded after induction of sepsis by the intraperitoneal injection of three susceptible and three multidrug-resistant isolates. To test whether comparative effect of the latter isolates on survival correlates with any difference of monocyte-mediated release of pro-inflammatory mediators, monocytes of two rats were in vitro stimulated for the production of TNF-alpha and of malondialdehyde. In vitro stimulation of human monocytes by the susceptible isolates elicited elevated production of malondiadeheyde, of IL-1beta and of IL-6 compared to stimulation by multidrug-resistant isolates. Similar differences were found for TNF-alpha and IL-8, but they were not statistically significant. Production of IL-10 and IL-12 was not detected after stimulation with any isolate. Levels of procalcitonin were similar after induction with either susceptible or multidrug-resistant isolates. Mean survival of animals was 7.56, 21.80 and 55.20 h, respectively, after challenge by the susceptible isolates and 28.89, 61.8 and more than 120 h, respectively, after challenge by the multidrug-resistant isolates. Differences of survival were accompanied by greater rodent monocyte-release of TNF-alpha and malondialdehyde after stimulation by the susceptible isolates compared to multidrug-resistant ones. It is concluded that considerable differences are encountered on the stimulation of human monocytes by susceptible and resistant isolates of Pseudomonas aeruginosa. These results correlate with in vivo evidence and might influence decision on therapeutics.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple/inmunología , Inmunidad Innata/inmunología , Infecciones por Pseudomonas/inmunología , Pseudomonas aeruginosa/inmunología , Animales , Calcitonina/análisis , Péptido Relacionado con Gen de Calcitonina , Electroforesis en Gel de Campo Pulsado/métodos , Técnicas para Inmunoenzimas/métodos , Interleucinas/análisis , Mediciones Luminiscentes , Masculino , Malondialdehído/análisis , Monocitos/inmunología , Precursores de Proteínas/análisis , Infecciones por Pseudomonas/tratamiento farmacológico , Ratas , Ratas Wistar , Factor de Necrosis Tumoral alfa/análisis
8.
J Postgrad Med ; 49(1): 11-6; discussion 16, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12865564

RESUMEN

BACKGROUND: To study whether Pseudomonas aeruginosa may directly trigger peroxidation of polyunsaturated fatty acids, since lipid peroxidation is a mechanism involved in the pathogenesis of sepsis. METHODS: Gamma-linolenic acid (GLA) was administered intravenously at a dose of 25mg/kg in an infusion time of 10 minutes to seven male rabbits. Blood samples were collected from the hepatic veins and from the carotid artery at regular time intervals. One clinical isolate was ex vivo incubated with the serum derived from the latter samples and concentrations of malondialdehyde (MDA) were determined during incubation in the growth medium by the thiobarbiturate assay. RESULTS: Elevated concentrations of MDA compared to their basal levels were found over the first three hours of incubation in the presence of samples collected 30 to 60 minutes after the end of the infusion of GLA. After infusion of GLA concentrations of arachidonic acid in the serum increased to concentrations comparable to those detected in sepsis. CONCLUSION: Direct triggering of lipid peroxidation by nosocomial isolates might be proposed as a pathogenetic mechanism of sepsis.


Asunto(s)
Infección Hospitalaria/microbiología , Peroxidación de Lípido , Pseudomonas aeruginosa/patogenicidad , Animales , Ácido Araquidónico/sangre , Infección Hospitalaria/sangre , Masculino , Malondialdehído/sangre , Pseudomonas aeruginosa/metabolismo , Conejos , Ácido gammalinolénico/administración & dosificación
9.
Eur J Vasc Endovasc Surg ; 24(2): 161-5, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12389240

RESUMEN

OBJECTIVE: To evaluate the association between Apolipoprotein AI (ApoAI), Apolipoprotein B100 (ApoB) and the presence of lower limb atherosclerotic occlusive disease. MATERIALS AND METHODS: Serum lipids, lipoprotein fractions, ApoAI, ApoB and Lp(a) were measured in 52 patients (28 diabetics and 24 non-diabetics) with lower limb occlusive disease. They were evaluated according to patients' glucose and compared with those in 75 healthy controls. RESULTS: There was a significant decrease in HDL-cholesterol and ApoAI serum levels (p = 0.000001) and an increase in Lp(a) (p = 0.000001) in patients as compared to controls. No difference was observed in total cholesterol, non HDL-cholesterol or triglycerides. Multiple regression analysis revealed a significant association between low ApoAI (or HDL) levels and the disease as well as between high Lp(a) levels and the disease. ApoAI (p = 0.0003), HDL-cholesterol (p = 0.00005) and total cholesterol (p = 0.01) levels were significantly lower in diabetic patients compared to non-diabetic patients. Lp(a) levels did not correlate with fasting glucose concentration. Multiple regression analysis revealed a significant association between low ApoAI (or HDL) levels and diabetes. CONCLUSION: Decreased ApoAI appears to be a main component of the dyslipidaemic serum profile observed in patients with atherosclerotic occlusive disease of the lower extremities. Increased Lp(a) levels is an independent risk factor. Decreased HDL-cholesterol is also involved in the dyslipidaemic profile.


Asunto(s)
Apolipoproteína A-I/sangre , Apolipoproteínas B/sangre , Arteriosclerosis/sangre , Diabetes Mellitus/sangre , Lipoproteína(a)/sangre , Enfermedades Vasculares Periféricas/sangre , Adulto , Apolipoproteína B-100 , Arteriosclerosis/complicaciones , Arteriosclerosis/fisiopatología , Complicaciones de la Diabetes , Diabetes Mellitus/fisiopatología , Femenino , Humanos , Pierna/irrigación sanguínea , Pierna/fisiopatología , Lípidos/sangre , Masculino , Enfermedades Vasculares Periféricas/etiología , Enfermedades Vasculares Periféricas/fisiopatología , Factores de Riesgo , Sensibilidad y Especificidad
10.
Artículo en Inglés | MEDLINE | ID: mdl-12213437

RESUMEN

In an attempt to achieve the safe intravenous administration of two n-6 polyunsaturated fatty acids (PUFAs), gamma-linolenic acid (GLA) and arachidonic acid (AA), and to study the subsequent changes on the total oxidant and antioxidant status, various steadily increasing doses of each acid were injected intravenously at different infusion times in 28 male rabbits. Blood samples were collected at 15-min time intervals by the hepatic veins and from the carotid artery; oxidant status was determined by the thiobarbiturate assay and total antioxidant status (TAS) was assessed by a colorimetric assay. Both n-6 PUFAs were administered with safety at a dose of 25 mg/kg within 10 min accompanied by an increase of malonodialdehyde concentrations in the hepatic veins and in the carotid artery 30-45 min, respectively, after the end of the infusion of GLA and/or AA. Similar changes did not occur in red cell membranes after the infusion of AA. TAS presented reciprocal changes to malonodialdehyde production; the main consumption of TAS was observed in all samples 30-60 min after the end of the infusion of n-6 PUFAs. The above-mentioned rapid alterations occurring in both serum oxidant and antioxidant status after GLA might have a future clinical therapeutic significance in conditions like cancer and disseminated infectious diseases.


Asunto(s)
Antioxidantes/análisis , Ácidos Grasos Omega-6/administración & dosificación , Ácidos Grasos Omega-6/farmacología , Oxidantes/sangre , Animales , Análisis Químico de la Sangre , Arterias Carótidas/efectos de los fármacos , Arterias Carótidas/metabolismo , Relación Dosis-Respuesta a Droga , Membrana Eritrocítica/efectos de los fármacos , Membrana Eritrocítica/metabolismo , Venas Hepáticas/efectos de los fármacos , Venas Hepáticas/metabolismo , Inyecciones Intravenosas , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Conejos
11.
Clin Exp Obstet Gynecol ; 29(4): 286-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12635747

RESUMEN

Intracytoplasmic sperm injection (ICSI) is widely employed today in cases of severe male factor infertility. This technique requires denuding the oocytes from the surrounding granulosa cells prior to sperm injection. One can thus assess oocyte maturity more accurately and can study the effects of various ovarian stimulation protocols on egg maturation and the rest of the parameters of the outcome of ICSI. The aim of the present study was to compare the outcome of ovarian stimulation using human menopausal gonadotropin (hMG) with that achieved by using highly purified follicle stimulating hormone (pFSH). The biological and clinical parameters of the outcome of ICSI in 99 subfertile couples were studied. Group A consisted of 46 patients to whom hMG was administered and Group B consisted of 53 patients to whom pFSH was employed for ovarian stimulation. The fertilization rate was significantly higher in the pFSH group but all other factors were similar, including the percentage of mature oocytes and pregnancy rate. The latter does not seem to be affected by the gonadotropin preparation employed for ovarian stimulation. This is very helpful for the physician to know since a gonadotropin with a lower cost can be employed and, in addition, shortage of some preparations of gonadotropins occurs frequently.


Asunto(s)
Fármacos para la Fertilidad Femenina/uso terapéutico , Menotropinas/uso terapéutico , Inducción de la Ovulación , Inyecciones de Esperma Intracitoplasmáticas , Administración Intranasal , Adulto , Buserelina/administración & dosificación , Química Farmacéutica , Esquema de Medicación , Femenino , Fármacos para la Fertilidad Femenina/administración & dosificación , Humanos , Masculino , Menotropinas/administración & dosificación , Embarazo , Índice de Embarazo , Estudios Prospectivos , Resultado del Tratamiento
12.
Nutr Metab Cardiovasc Dis ; 11(6): 388-93, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12055703

RESUMEN

BACKGROUND AND AIM: It has become apparent that dehydroepiandrosterone (DHEA) plays a protective role in atherosclerosis, but its influence on serum lipids has not yet been clarified. The aim of this study was to evaluate the association of endogenous adrenal C19 steroid hormones [(DHEA) and androstenedione (ASD)] and serum lipoprotein levels. METHODS AND RESULTS: The serum concentrations of dehydroepiandrosterone sulphate (DHEA-S), ASD, total and free testosterone, estradiol, total cholesterol, LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), triglycerides, apolipoprotein AI (ApoAI) and apolipoprotein B100 (ApoB100) were measured in a sample of 88 healthy men. Statistical analysis using Spearman's correlation coefficient showed a positive correlation between DHEA-S levels and ApoAI (p = 0.034), a negative correlation between ASD and triglycerides (p = 0.005), a positive correlation between ASD and LDL-C (p = 0.005), and a negative correlation between estradiol and HDL-C (p = 0.042). Multiple regression analysis revealed that DHEA-S is an independent factor for ApoAI, ASD an independent factor for triglycerides and LDL-C, and age an independent factor for ApoB100; estradiol was found to be a suggestive factor for HDL. CONCLUSIONS: The results suggest that the plasma levels of DHEA-S and ASD (adrenal C19 steroid hormones) correlate with the plasma lipid profiles of healthy men. It remains to be seen whether this profile is favourable.


Asunto(s)
Androstenodiona/sangre , Apolipoproteínas/sangre , Arteriosclerosis/sangre , Colesterol/sangre , Deshidroepiandrosterona/sangre , Triglicéridos/sangre , Adulto , Apolipoproteína A-I/sangre , Apolipoproteínas B/sangre , Arteriosclerosis/prevención & control , Índice de Masa Corporal , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Estradiol/sangre , Humanos , Masculino , Persona de Mediana Edad , Análisis de Regresión , Testosterona/sangre
13.
Eur J Vasc Endovasc Surg ; 20(1): 57-60, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10906299

RESUMEN

OBJECTIVE: To evaluate the association between Lp(a) lipoprotein levels, other serum lipids and the presence of lower limb atherosclerotic occlusive disease. MATERIALS AND METHODS: Angiographic findings in 36 patients were related to serum Lp(a). Total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol and Lp(a) levels were compared with those of 73 age- and sex-matched healthy controls. RESULTS: Atheromatous lesions were localised in the femoropopliteal ( approximately 60%) and aortoiliac ( approximately 40%) segments. The number of stenosed arteries was > or =2 and the range of stenosis severity was between 40% and 100%. There was a significant increase in serum Lp(a) (p= 0.000001) and a decrease in serum HDL (p= 0.000009) levels in patients compared to controls. No difference was observed in total cholesterol, LDL-cholesterol or triglyceride. However, the ratio of total cholesterol/HDL-cholesterol was significantly higher (p= 0.005) in patients. CONCLUSION: A dyslipidaemic serum profile, characterised by increased Lp(a) levels and decreased HDL-cholesterol levels, is associated with atherosclerotic occlusive disease of the lower extremities.


Asunto(s)
Arteriosclerosis/sangre , Isquemia/sangre , Pierna/irrigación sanguínea , Lipoproteína(a)/sangre , Anciano , Anciano de 80 o más Años , Arteriosclerosis/diagnóstico , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Humanos , Isquemia/diagnóstico , Masculino , Persona de Mediana Edad , Triglicéridos/sangre
14.
Antimicrob Agents Chemother ; 44(8): 2187-9, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10898699

RESUMEN

Twenty-six multidrug-resistant Pseudomonas aeruginosa isolates were exposed over time to 300 microg of gamma-linolenic acid or arachidonic acid per ml or to the combination of both acids at 150 microg/ml each with ceftazidime and amikacin with or without albumin to observe the in vitro interactions of the antibiotics. Antibiotics and albumin were applied at their levels found in serum. Synergy between acids and antibiotics was found against 13 isolates, and it was expressed after 5 h of growth in the presence of albumin. The results indicate that further application in experimental infection models is merited.


Asunto(s)
Amicacina/farmacología , Ceftazidima/farmacología , Resistencia a Múltiples Medicamentos/fisiología , Ácidos Grasos Insaturados/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Antibacterianos , Cefalosporinas/farmacología , Sinergismo Farmacológico , Ácidos Grasos Omega-6 , Humanos , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa/crecimiento & desarrollo
15.
Clin Chim Acta ; 297(1-2): 103-21, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10841913

RESUMEN

Human neutral brush border endopeptidase (NEP) was purified from the urine of patients suffering from acute toxic tubulointerstitial nephropathy. An enzyme preparation with specific activity of 102 Ug(-1) protein was obtained. The urinary activities of neutral endopeptidase and alanine aminopeptidase were measured in patients with renal disease and in 30 control patients, resulting in a reference range from 0.1 to 0.7 Ug(-1) creatinine and 1.4-14.1 Ug(-1) creatinine, respectively. Urine enzyme activities were highest in patients with acute tubulotoxic renal diseases. Neutral endopeptidase and alanine aminopeptidase activities were found to be 6.5- and 10-fold higher than the upper value of the reference range, respectively. Smaller increases in the rate of excretion of these enzymes (2.5- and 3.5-fold), respectively, were observed in patients suffering from acute tubular insufficiency and even lower increases, 2- and 1.5-fold, respectively, were observed in patients with chronic renal diseases. In diabetics and kidney transplant patients the enzyme excretion rates were within the reference range. Assay of both transmembrane metalloproteinases in urine may prove valuable in serving as markers for renal toxicity. Together with beta-NAG these enzymes could be employed as differentiation markers between acute and chronic tubular insufficiency.


Asunto(s)
Enfermedades Renales/enzimología , Neprilisina/orina , Cromatografía por Intercambio Iónico , Inhibidores Enzimáticos/farmacología , Estabilidad de Enzimas , Humanos , Concentración de Iones de Hidrógeno , Enfermedades Renales/orina , Cinética , Microvellosidades/enzimología , Neprilisina/antagonistas & inhibidores , Neprilisina/aislamiento & purificación
18.
Artículo en Inglés | MEDLINE | ID: mdl-9654401

RESUMEN

Based on previous findings that gamma-linolenic acid (GLA) inhibits Escherichia coli growth and provokes the induction of strains resistant to aminoglycosides, 19 Pseudomonas aeruginosa strains were exposed in vitro over time to GLA, to arachidonic acid (AA) and to their combination in the presence or absence of vitamin E. All acids were used at a 300 microg/ml concentration, whereas vitamin E was added as an antioxidant. Lipid peroxidation was evaluated by the thiobarbiturate assay measuring malonodialdehyde (MDA) production. It was found that GLA or AA killed 5-10% of strains at 24 h of growth, whereas when applied in combination their effect involved 100% of strains at 24 h and was limited to 68% of strains in the presence of vitamin E (P< 0.01). MDA production was time-dependent and it was restrained by vitamin E (P < 0.01). Post acid exposure, 27% to 37% of the survived strains became resistant to diverse antimicrobial agents and mainly to ticarcillin, to ceftazidime and to amikacin; no strain developed resistance in the presence of vitamin E. It is concluded that GLA and AA interact bactericidally on P. aeruginosa isolates, inducing the development of strains resistant to beta-lactams and to aminoglycosides; their action might be mediated through their peroxides. Further research is necessary to establish the clinical application of these in vitro findings.


Asunto(s)
Ácidos Grasos Insaturados/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Amicacina/farmacología , Resistencia a la Ampicilina , Antibacterianos/farmacología , Ácido Araquidónico/farmacología , Ceftazidima/farmacología , Resistencia a las Cefalosporinas , Cefalosporinas/farmacología , Recuento de Colonia Microbiana , Farmacorresistencia Microbiana , Resistencia a Múltiples Medicamentos , Gentamicinas/farmacología , Imipenem/farmacología , Peroxidación de Lípido/efectos de los fármacos , Malondialdehído/metabolismo , Pruebas de Sensibilidad Microbiana , Resistencia a las Penicilinas , Penicilinas/farmacología , Piperacilina/farmacología , Pseudomonas aeruginosa/crecimiento & desarrollo , Pseudomonas aeruginosa/metabolismo , Especificidad de la Especie , Tienamicinas/farmacología , Ticarcilina/farmacología , Tobramicina/farmacología , Vitamina E/farmacología , Ácido gammalinolénico/farmacología
19.
J Cardiovasc Risk ; 3(3): 277-80, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8863099

RESUMEN

OBJECTIVE: To investigate lipoprotein(a) levels in a Greek population sample. METHOD: Serum apolipoprotein [Apo(a)] concentrations were measured in 220 men and 190 women aged 55-65 years without a history of effort angina or myocardial infarction. RESULTS: The distributions of Apo(a) and lipoprotein(a) [LP(a)] levels were highly skewed both in men and in women. The level of 30 mg/dl Lp(a) corresponded to the 77th percentile of the Lp(a) distribution in men but to the 66th percentile in women. Women had significantly higher values of Apo(a) or Lp(a) concentration than men. High-density lipoprotein cholesterol levels tended to be higher in women, but not in men, belonging to the fourth and fifth quintiles of the Lp(a) distribution than in those belonging to the three lower quintiles.


Asunto(s)
Lipoproteína(a)/sangre , Anciano , HDL-Colesterol/sangre , Enfermedad de la Arteria Coronaria/sangre , Femenino , Grecia , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia , Factores de Riesgo
20.
Int J Antimicrob Agents ; 6(1): 47-50, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18611685

RESUMEN

Recent evidence derived from a mouse infection model implies an 'anti-infective' role of polyunsaturated fatty acids (PUFAs) which could not be attributed to an alteration of eicosanoid or cytokine biosynthesis provoked by them. In order to investigate that role, seven Pseudomonas aeruginosa nosocomial pathogens were in vitro exposed to 200 and 300 mug/ml of two PUFAs, arachidonic acid (AA) and gamma-linolenic acid (GLA), by performing 43 time-kill curves. Both PUFAs were found to inhibit P. aeruginosa growth as compared to their controls, an effect maximized at 5 h of incubation and minimized at 24 h. The strains that survived after the 24 h AA and GLA exposure were removed from the culture medium with added AA or GLA; half of these strains acquired enormously higher MIC and MBC values to aminoglycosides compared to their relevant controls. The possible mechanism of action of AA and GLA on P. aeruginosa and the clinical relevance of the presented findings is a matter of further research.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...